First report of overall survival for ipilimumab plus nivolumab from the phase III Checkmate 067 study in advanced melanoma

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles